PT  - JOURNAL ARTICLE
AU  - Ivan T. Lee
AU  - Tsuguhisa Nakayama
AU  - Chien-Ting Wu
AU  - Yury Goltsev
AU  - Sizun Jiang
AU  - Phillip A. Gall
AU  - Chun-Kang Liao
AU  - Liang-Chun Shih
AU  - Christian M. Schürch
AU  - David R. McIlwain
AU  - Pauline Chu
AU  - Nicole A. Borchard
AU  - David Zarabanda
AU  - Sachi S. Dholakia
AU  - Angela Yang
AU  - Dayoung Kim
AU  - Tomoharu Kanie
AU  - Chia-Der Lin
AU  - Ming-Hsui Tsai
AU  - Katie M. Phillips
AU  - Raymond Kim
AU  - Jonathan B. Overdevest
AU  - Matthew A. Tyler
AU  - Carol H. Yan
AU  - Chih-Feng Lin
AU  - Yi-Tsen Lin
AU  - Da-Tian Bau
AU  - Gregory J. Tsay
AU  - Zara M. Patel
AU  - Yung-An Tsou
AU  - Chih-Jaan Tai
AU  - Te-Huei Yeh
AU  - Peter H. Hwang
AU  - Garry P. Nolan
AU  - Jayakar V. Nayak
AU  - Peter K. Jackson
TI  - Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers
AID  - 10.1101/2020.05.08.20092866
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.08.20092866
4099  - http://medrxiv.org/content/early/2020/05/12/2020.05.08.20092866.short
4100  - http://medrxiv.org/content/early/2020/05/12/2020.05.08.20092866.full
AB  - We investigated the expression and subcellular localization of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2 (ACE2), within the upper (nasal) and lower (pulmonary) respiratory tracts of healthy human donors. We detected ACE2 protein expression within the cilia organelle of ciliated airway epithelial cells, which likely represents the initial or early subcellular site of SARS-CoV-2 viral entry during respiratory transmission. We further determined whether ACE2 expression in the cilia of upper respiratory cells was influenced by patient demographics, clinical characteristics, co-morbidities, or medication use, and found no evidence that the use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARBs) increases ACE2 protein expression.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Parker Institute for Cancer Immunotherapy (G.P.N.), Food and Drug Administration (HHSF223201610018C and DSTL/AGR00980) (G.P.N.), Fast Grant Funding for COVID-19 Science (G.P.N. and P.K.J.), the National Institutes of Health 1R01AI149672-01 (G.P.N.), P30DK116074 (P.K.J.), the Rachford & Carlotta A. Harris Endowed Chair (G.P.N.), CA Institute of Regenerative Medicine (DISC2-09637) (J.V.N.), Defense Advanced Research Project Agency (HR001118S0037-PREPARE-FP-001) (J.V.N.), The Stanford Initiative to Cure Hearing Loss (SICHL) (P.A.G., J.V.N.), The Operndorf Foundation (P.A.G., J.V.N.), The PD Foundation (J.V.N.), Stanford Translational Research and Applied Medicine (TRAM) Pilot Grant (I.T.L.), Thrasher Research Fund Early Career Award (I.T.L.), Stanford Maternal and Child Health Research Institute (MCHRI) Clinical (MD) Trainee Support Award (I.T.L., Ernest and Amelia Gallo Endowed Postdoctoral Fellow), Leukemia & Lymphoma Society Career Development Program (S.J.).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analyzed during this study are included in this published article or available upon reasonable request.